report of a novel mutation in the slc26a2 gene foud in a colomian adult patient with diastrophic dysplasia
;Tatiana Pineda;Antonio Rossi;Luisa Bonafe;Andrea Superti Furga;Harvy M. Velasco
european journal of cancer prevention : the official journal of the european cancer prevention organisation (ecp)2013Vol. 61pp. 255-259
388
pineda2013revistareport
Abstract
Background. Diastrophic dysplasia is an osteochondrodysplasia
belonging to the group of dysplasias caused by mutations in
the diastrophic dysplasia sulfate transporter. This sindrome is
a micromelic dysplasia with multiple bone deformities of the
hands, feet, knees and spine.
Objective. Describe the first report of diastrophic displasia
in Colombia
Materials and methods. In this paper a Colombian adult
patient with diastrophic dysplasia whose clinical diagnosis
was confirmed at the molecular level is reported.
Results. In this first report of diastrophic dysplasia in Colombia
we found that the patient was compound heterozygote for the
already reported Arg279Trp substitution and an unpublished
mutation, a Ser157Thr substitution in the SLC26A2 gene.
Conclusion. Bioinformatic analysis on the latter mutation
suggested that it could correspond to a deleterious mutation
because it is in a highly conserved domain of the sulfate
transporter